Aktuellt
SENASTE
Redeye provides its initial comments on Nanologica's Q3 report, which showed softer-than-expected sales. However, we view the report as relatively undramatic, as the key value drivers remain focused on production improvements and converting customer evaluations into production orders. In our view, the outlook for these drivers remains positive.
LÄS MER
